Showing results (11-20 of 1,618) with videos related to
Sort By:
Pageof 162
Journal of Clinical Medicine|May 23, 2020
Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 PandemicFerdinando D'Amico, Laurent Peyrin-Biroulet, Silvio DaneseExpert Opinion on Investigational Drugs|May 30, 2023
Promising phase II biologics for future Crohn's disease therapyPauline Wils, Silvio Danese, Laurent Peyrin-BirouletJournal of Crohn'S & Colitis|June 3, 2017
Positioning Ustekinumab in Crohn's Disease: From Clinical Evidence to Clinical PracticeSilvio Danese, Stefanos Bonovas, Laurent Peyrin-BirouletJournal of Crohn'S & Colitis|May 13, 2022
Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment AlgorithmFerdinando D'Amico, Laurent Peyrin-Biroulet, Silvio DaneseCurrent Drug Targets|June 19, 2012
Bowel damage assessment in Crohn's disease by magnetic resonance imagingGionata Fiorino, Laurent Peyrin-Biroulet, Silvio DaneseNature Reviews. Gastroenterology & Hepatology|August 19, 2015
Biologic agents for IBD: practical insightsSilvio Danese, Lucine Vuitton, Laurent Peyrin-BirouletCurrent Drug Targets|June 10, 2016
Evolving Treatment Algorithms in Crohn's DiseaseAndrew Wisniewski, Silvio Danese, Laurent Peyrin-BirouletCurrent Drug Targets|March 10, 2010
Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic reviewAbderrahim Oussalah, Silvio Danese, Laurent Peyrin-BirouletJournal of Clinical Medicine|July 29, 2020
Adaptive Designs: Lessons for Inflammatory Bowel Disease TrialsFerdinando D'Amico, Silvio Danese, Laurent Peyrin-BirouletExpert Opinion on Drug Discovery|June 27, 2025
The preclinical discovery and development of upadacitinib for the treatment of Crohn's diseaseSophie Vieujean, Silvio Danese, Laurent Peyrin-BirouletPageof 162